Based on the key indicators related to Dolby Laboratories' liquidity, profitability, solvency, and operating efficiency, Dolby Laboratories is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At present, Dolby Laboratories' Cash is projected to increase significantly based on the last few years of reporting. The current year's Cash And Short Term Investments is expected to grow to about 746.4 M, whereas Total Assets are forecasted to decline to about 2 B. Key indicators impacting Dolby Laboratories' financial strength include:
Investors should never underestimate Dolby Laboratories' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Dolby Laboratories' cash flow, debt, and profitability to make informed and accurate decisions about investing in Dolby Laboratories.
Cash And Equivalents
907.62 Million
Dolby
Select Account or Indicator
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Enterprise Value Over E B I T D A
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Return On Capital Employed
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Days Of Inventory Outstanding
Days Of Sales Outstanding
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Price Sales Ratio
Return On Assets
Net Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Netincome
Change To Liabilities
Stock Based Compensation
Change To Account Receivables
Other Cashflows From Investing Activities
Investments
Change Receivables
Net Borrowings
Total Cashflows From Investing Activities
Exchange Rate Changes
Dividends Paid
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Total Stockholder Equity
Net Debt
Cash
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Total Current Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Other Liab
Property Plant And Equipment Net
Current Deferred Revenue
Retained Earnings
Accounts Payable
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Net Receivables
Good Will
Common Stock Total Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Short Term Investments
Net Tangible Assets
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Capital Surpluse
Additional Paid In Capital
Deferred Long Term Liab
Long Term Investments
Non Current Liabilities Other
Deferred Long Term Asset Charges
Cash And Equivalents
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Depreciation And Amortization
Selling General Administrative
Net Income Applicable To Common Shares
Minority Interest
Selling And Marketing Expenses
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Dolby Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dolby Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Dolby Laboratories' assets may result in an increase in income on the income statement.
Please note, the presentation of Dolby Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dolby Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Dolby Laboratories' management manipulating its earnings.
Dolby Laboratories Stock Summary
Dolby Laboratories competes with Nasdaq, Abcellera Biologics, Equinix, Valneva SE, and Genfit. Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California. Dolby Laboratories operates under Information Technology Services classification in the United States and is traded on New York Stock Exchange. It employs 2368 people.
Specialization
Information Technology, Technology Hardware & Equipment
Comparative valuation techniques use various fundamental indicators to help in determining Dolby Laboratories's current stock value. Our valuation model uses many indicators to compare Dolby Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dolby Laboratories competition to find correlations between indicators driving Dolby Laboratories's intrinsic value. More Info.
Dolby Laboratories is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Dolby Laboratories is roughly 1.73 . At present, Dolby Laboratories' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dolby Laboratories' earnings, one of the primary drivers of an investment's value.
Dolby Laboratories' Earnings Breakdown by Geography
Dolby Laboratories Systematic Risk
Dolby Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dolby Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Dolby Laboratories correlated with the market. If Beta is less than 0 Dolby Laboratories generally moves in the opposite direction as compared to the market. If Dolby Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dolby Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dolby Laboratories is generally in the same direction as the market. If Beta > 1 Dolby Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Dolby Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dolby Laboratories' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Dolby Laboratories growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.88)
At present, Dolby Laboratories' Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
Dolby Laboratories November 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Dolby Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dolby Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dolby Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Dolby Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dolby Laboratories's daily price indicators and compare them against related drivers.
When running Dolby Laboratories' price analysis, check to measure Dolby Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dolby Laboratories is operating at the current time. Most of Dolby Laboratories' value examination focuses on studying past and present price action to predict the probability of Dolby Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dolby Laboratories' price. Additionally, you may evaluate how the addition of Dolby Laboratories to your portfolios can decrease your overall portfolio volatility.